Latest Breaking News On - Consultant nephrologist - Page 1 : comparemela.com

Invizius's Pioneering Dialysis Product H-Guard® Completes First In-Human Clinical Study

/PRNewswire/ Invizius Limited ("Invizius"), a biotechnology company developing breakthrough treatments for patients on dialysis, announces that eight.

Invizius's Pioneering Dialysis Product H-Guard® Completes First In-Human Clinical Study

Study demonstrated safety and tolerability of H-Guard®, a second generation complement regulator, designed to address serious immune system-driven complications of dialysis.Encouraging biomarker data positions H-Guard for upcoming Acute Kidney Injury (AKI) trial focused on reducing complement mediated renal tubu.

50 pc high BP patients may suffer from kidney damage: Doctors

About 50 per cent of people with high blood pressure (BP) or hypertension are likely to experience kidney damage in the long term and may require dialysis or transplantation, said experts on Thursday ahead of World Hypertension Day.World .

50 Pc High BP Patients May Suffer From Kidney Damage: Doctors

Kidney Damage in 50% of High Blood Pressure Cases

World Hypertension Day: Kidney impairment affects 50% of individuals diagnosed with high blood pressure (hypertension), underscoring the severity of the condition.